Compile Data Set for Download or QSAR
Report error Found 16 Enz. Inhib. hit(s) with all data for entry = 12076
TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676691(US20240166645, Compound I-3)
Affinity DataIC50: 3.94nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676699(US20240166645, Compound I-23)
Affinity DataIC50: 4.90nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676689(US20240166645, Compound I-1)
Affinity DataIC50: 6.87nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676697(US20240166645, Compound I-21)
Affinity DataIC50: 6.90nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676690(US20240166645, Compound I-2)
Affinity DataIC50: 7.73nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676688(US20240166645, Control compound II)
Affinity DataIC50: 8.15nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676687(US20240166645, Control compound I)
Affinity DataIC50: 8.58nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676696(US20240166645, Compound I-19)
Affinity DataIC50: 9.5nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676692(US20240166645, Compound I-5)
Affinity DataIC50: 10nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676694(US20240166645, Compound I-15)
Affinity DataIC50: 14.4nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676695(US20240166645, Compound I-16)
Affinity DataIC50: 16.1nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676698(US20240166645, Compound I-22)
Affinity DataIC50: 21.7nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676693(US20240166645, Compound I-12)
Affinity DataIC50: 22.2nMAssay Description:Table 1: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and the compound was serially diluted using 1× test buffer. 0....More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676687(US20240166645, Control compound I)
Affinity DataIC50: 45nMAssay Description:Table 2: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and serially diluted using 1× test buffer (modified Tris buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676689(US20240166645, Compound I-1)
Affinity DataIC50: 59nMAssay Description:Table 2: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and serially diluted using 1× test buffer (modified Tris buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent

TargetSon of sevenless homolog 1/GTPase KRas [G12C](Human)
Wuhan Humanwell Innovative Drug

US Patent
LigandPNGBDBM676690(US20240166645, Compound I-2)
Affinity DataIC50: 102nMAssay Description:Table 2: The compound to be tested was prepared into a 10 mM stock solution with DMSO, and serially diluted using 1× test buffer (modified Tris buffe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/26/2024
Entry Details
Go to US Patent